Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans -Activators
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The tetracycline (Tet)-dependent regulatory system has been widely used for controlling gene expression. The Tet-on version of the system, in which the reverse Tet-responsive transcriptional activator (rtTA) is positively regulated by Tet or its analogs, such as doxycycline (Dox), is of potential utility for gene therapy applications in humans. However, rtTA may display a high basal activity, especially when delivered in vivo by using episomal vectors such as plasmids. Two novel Dox-inducible activators, called rtTA2(S)-S2 and rtTA2(S)-M2, which have a significantly lower basal activity than rtTA in stably transfected cell lines, have been described. In this study we tested the capability of these trans-activators to control expression of mouse erythropoietin (mEpo) and to modulate hematocrit (Hct) increase in vivo on delivery of plasmids into quadriceps muscles of adult mice by DNA electroinjection. Both rtTA2(S)-M2 and rtTA2(S)-S2 displayed a considerably lower background activity and higher window of induction than rtTA in vivo. Moreover, a stringent control of mEpo gene expression and Hct levels in the absence of any background activity was maintained over a 10-month period by injecting as little as 1 microg of a single plasmid containing the rtTA2(S)-S2 expression cassette and the Tet-responsive mEpo cDNA. This constitutes the first report of a stringent ligand-dependent control of gene expression in vivo obtained by delivering a single plasmid encoding both the trans-activator and the regulated gene. Notably, the rtTA2(S)-S2-based system was induced by oral doses of doxycycline comparable to those normally used in clinical practice in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“…chimeric activator (called the Tet-responsive transcriptional activator, or tTA) binds to and activates transcription from a synthetic promoter containing tet operator DNA ( tetO )-binding sites upstream of the cytomegalovirus (CMV) minimal promoter (called P hCMV* 2 1 ) (Gossen and Bujard, 1992).”
Self-citationTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 2×
“An alternative version of this system is based on a mutated form of tTA called reverse tTA (rtTA), which binds to tetO only in the presence of the ligand (Gossen et al ., 1995).”
Self-citationControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550 · cited 1×
“The tetracycline (Tet)-dependent system has been extensively used to regulate gene expression in cultured cells, plants, rodents, yeast, and Drosophila (Weinmann et al., 1994; Mayford et al., 1996; Gari et al., 1997; Bieschke et al., 1998; Lavon et al., 2000).”
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928
Self-citation
Cited by
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Clonal dynamics of native haematopoiesis
Sun, J., Ramos, A., Chapman, B., Johnnidis, J. B., Le, L., Ho, Y.-J., Klein, A., Hofmann, O., & Camargo, F. D. (2014) · Nature · doi:10.1038/nature13824 · Cited by 821
Matthews, V. B., Åström, M.-B., Chan, M. H. S., Bruce, C. R., Krabbe, K. S., Prelovsek, O., Åkerström, T., Yfanti, C., Broholm, C., Mortensen, O. H., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1364-1 · Cited by 722
DNA electrotransfer: its principles and an updated review of its therapeutic applications
André, F., & Mir, L. M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302367 · Cited by 292
Regulatable gene expression systems for gene therapy applications: progress and future challenges
Goverdhana, S., Puntel, M., Xiong, W., Zirger, J. M., Barcia, C., Curtin, J. F., Soffer, E. B., Mondkar, S., King, G. D., Hu, J., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.022 · Cited by 283
“More recently, novel tetracycline-regulated systems that display high inducibility and very low to negligible basal activity have been developed [148-150].”
Background
Metadata
- Authors
- Lamartina, S., Roscilli, G., Rinaudo, C. D., Sporeno, E., Silvi, L., Hillen, W., Bujard, H., Cortese, R., Ciliberto, G., & Toniatti, C.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-01-20
- Volume
- 13
- Issue
- 2
- Pages
- 199-210
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2181006996
- Cited by
- 93
- References
- 4
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans -Activators. https://app.cochat.ai/papers/10.1089/10430340252769734
- The paper
- Lamartina, S., Roscilli, G., Rinaudo, C. D., Sporeno, E., Silvi, L., Hillen, W., Bujard, H., Cortese, R., Ciliberto, G., & Toniatti, C. (2002). Stringent Control of Gene Expression In Vivo by Using Novel Doxycycline-Dependent Trans -Activators. Human Gene Therapy. https://doi.org/10.1089/10430340252769734
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.